Bcl-2 as a clinical prognostic marker. | Download Table
Targeting BCL2 for the Treatment of Lymphoid Malignancies - ScienceDirect
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect
Frontiers | The Multifaceted Roles of the BCL-2 Family Member BOK
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
The prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma. | Semantic Scholar
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia | Haematologica
Bcl-2 - Wikipedia
PDF) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | ResearchGate
PDF) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | ResearchGate
Frontiers | BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
Bcl-2 as a clinical prognostic marker. | Download Table
Noncanonical Cell Fate Regulation by Bcl-2 Proteins: Trends in Cell Biology
IVD Antibody Development Services for BCL-2 Marker - Creative Biolabs
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance | Cell Death & Disease
IVD Antibody Development Services for BCL-2 Marker - Creative Biolabs
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Ancient and conserved functional interplay between Bcl-2 family proteins in the mitochondrial pathway of apoptosis | Science Advances
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | Scientific Reports
